KIR2DL3 Antikörper (AA 22-245)

Produktnummer ABIN7157503

Produktdetails anti-KIR2DL3 Antikörper

Target: KIR2DL3 (Killer Cell Immunoglobulin-Like Receptor, Two Domains, Long Cytoplasmic Tail, 3 (KIR2DL3))

Bindungsspezifität: AA 22-245

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser KIR2DL3 Antikörper ist unkonjugiert

Applikation: ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)

Kreuzreaktivität: Human

Aufreinigung: >95%, Protein G purified

Immunogen: Recombinant Human Killer cell immunoglobulin-like receptor 2DL3 protein (22-245AA)

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Details zu KIR2DL3

Target: KIR2DL3 (Killer Cell Immunoglobulin-Like Receptor, Two Domains, Long Cytoplasmic Tail, 3 (KIR2DL3))

Andere Bezeichnung: KIR2DL3 (KIR2DL3 Produkte)

Synonyme: CD158B2 antikoerper, CD158b antikoerper, GL183 antikoerper, KIR-023GB antikoerper, KIR-K7b antikoerper, KIR-K7c antikoerper, KIRCL23 antikoerper, NKAT antikoerper, NKAT2 antikoerper, NKAT2A antikoerper, NKAT2B antikoerper, p58 antikoerper, killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 3 antikoerper, KIR2DL3 antikoerper

Hintergrund:

Background: Receptor on natural killer (NK) cells for HLA-C alleles (HLA-Cw1, HLA-Cw3 and HLA-Cw7). Inhibits the activity of NK cells thus preventing cell lysis.

Aliases: CD158 antigen like family member B2 antibody, CD158 antigen-like family member B2 antibody, CD158b antibody, CD158b2 antibody, GL183 antibody, KI2L3_HUMAN antibody, Killer cell immunoglobulin like receptor two domains long cytoplasmic tail 3 antibody, Killer cell immunoglobulin-like receptor 2DL3 antibody, Killer inhibitory receptor cl 2-3 antibody, Killer inhibitory receptor CL2 3 antibody, KIR 023GB antibody, KIR-023GB antibody, KIR-K7b antibody, KIR-K7c antibody, KIR023GB antibody, KIR2DL3 antibody, KIR2DS5 antibody, KIRCL23 antibody, MHC class I NK cell receptor antibody, Natural killer associated transcript 2 antibody, Natural killer cell inhibitory receptor KIR2DL3 antibody, Natural killer-associated transcript 2 antibody, NKAT antibody, NKAT-2 antibody, NKAT2 antibody, NKAT2a antibody, NKAT2b antibody, p58 antibody, p58 natural killer cell receptor clone CL 6 antibody, p58 natural killer cell receptor clone CL-6 antibody, p58 NK Receptor antibody, p58 NK receptor CL 6 antibody, p58 NK receptor CL-6 antibody, p58.2 MHC class I specific NK receptor antibody, p58.2 MHC class-I-specific NK receptor antibody

UniProt: P43628

Pathways: Cancer Immune Checkpoints